CRUK Consent Forms – NET and Prostate Cancer Update

The regimen specific consent forms for neuroendocrine and adrenal cancers have been reviewed, updated and added to the CRUK website.

In addition, a new consent form for prostate has been added as well.

The forms can be found at www.cruk.org/sact_consent.

The new forms added to the neuroendocrine and adrenal cancer group are:

  1. Fluorouracil, Carboplatin and Streptozocin (FCarboSt)
  2. Gemcitabine and Capecitabine
  3. Oxaliplatin, Irinotecan and Fluorouracil (FOLFOXIRI)
  4. 177-Lutetium Dotatate

 

The new form added for prostate is:

  1. Darolutamide – Docetaxel with ADT

 

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

 

Any questions, please do let me know.

 

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article